IP Verse

Catalyst Pharmaceuticals, Inc. V. Lupin Ltd. - 1:23-cv-00229

Explore the details of the Catalyst Pharmaceuticals, Inc. V. Lupin Ltd. case under case number 1:23-cv-00229 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00229
Filing Date
Mar 2, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Catalyst Pharmaceuticals, Inc. -
Lupin Ltd. -

Patents Involved in the Case

This case involves 6 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11268128B2
-US10626088B2
-US10793893B2
-US11274332B2
-US11274331B2
-US11060128B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Mar 2, 2023Summons Issued as to Lupin Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc. on 3/2/2023. (Attachments: # 1 Summons Issued Lupin Ldt., # 2 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) (Entered: 03/02/2023)PACER Document
Mar 2, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by SERB SA. (jfm) (Entered: 03/02/2023)PACER Document
Mar 2, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalyst Pharmaceuticals, Inc. (jfm) (Entered: 03/02/2023)PACER Document
Mar 2, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,626,088; US 10,793,893; US 11,060,128; US 11,268,128; US 11,274,331; US 11,274,332. (jfm) (Entered: 03/02/2023)PACER Document
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 2, 2023COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(jfm) (Entered: 03/02/2023)Attachment
Mar 7, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Catalyst - 1/27/2023; SERB - 1/30/2023. Date of Expiration of Patents: Various. Thirty Month Stay Deadline: 7/30/2025. (dlw) (Entered: 03/09/2023)PACER Document
May 5, 2023NOTICE of Voluntary Dismissal by Catalyst Pharmaceuticals, Inc., SERB SA as to all Defendants (Viceconte, Christopher) (Entered: 05/05/2023)PACER Document
May 5, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 05/05/2023)PACER Document
Mar 8, 2023Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)PACER Document
Mar 9, 2023CORRECTING ENTRY: D.I. 7 has been deleted from the docket and re-filed using the proper event code: ANDA Form found under civil, other documents. (dlw)PACER Document
May 5, 2023CASE CLOSED (dlw)PACER Document